Business Context and Reporting Period
This Form 8-K is filed by PharmAthene, Inc. (not Altimmune, Inc.) on August 10, 2011. The report announces the financial and operating results for the quarter ended June 30, 2011. The company is incorporated in Delaware and maintains its principal executive offices in Annapolis, Maryland.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that results for the quarter ended June 30, 2011, have been issued.
Guidance, Outlook, and Risks
The text contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It explicitly states that the information in this report, including the referenced press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name is PharmAthene, Inc., as the input metadata incorrectly listed Altimmune, Inc.
- Locate and review Exhibit 99.1 (the press release dated August 10, 2011) to obtain actual financial figures.
- Confirm the specific financial results for the quarter ended June 30, 2011, as they are not present in the 8-K body text.